Whalerock Point Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Whalerock Point Partners's LLY Position: Q2 2026 in Review
Whalerock Point Partners increased its Eli Lilly (LLY) stake by 0.15% in Q2 2026, buying an estimated $4.09K and bringing the position to 2,589 shares worth $3.11M. The position accounts for 0.53% of the portfolio, ranked #40.
Whalerock Point Partners first reported a position in LLY in Q2 2020 and has held it in 25 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Whalerock Point Partners held 2,589 shares of Eli Lilly worth $3.11M as of Q2 2026.
- Whalerock Point Partners bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
- Eli Lilly made up 0.53% of Whalerock Point Partners's portfolio in Q2 2026, its #40 holding.
- Whalerock Point Partners first reported a position in Eli Lilly in Q2 2020 and has held it in 25 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Whalerock Point Partners's 13F filing for Q2 2026, filed 13 Aug 2026.